Skip to main content
Premium Trial:

Request an Annual Quote

Agilent s LSCA Unit Grows 3 Percent in Fiscal Q2 as Total Receipts Slide 8 Percent

NEW YORK, May 17 (GenomeWeb News) - Agilent Technologies yesterday reported an 8-percent drop in revenues and decreased earnings for its second fiscal quarter, though contributions from the life sciences and chemical analys segment grew 3 percent.

 

Revenue for the quarter ended April 30 fell to $1.7 billion from $1.8 billion during the same period last year. Receipts from the company's life sciences and chemical analysis segment increased to $344 million from $333 during the same quarter.

 

Research and development costs increased slightly, to $248 million from $237 million during the second quarter of 2004.

 

Net earnings for the quarter fell to $95 million, or $.19 per share, from $104 million, or $.21 per share, during the year-ago period.

 

As of April 30, Agilent had $2.7 billion in cash and cash equivalents.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.